COVID-19 in 17 Italian Pediatric Emergency Departments

Niccolò Parri1, Matteo Lenge2,3,4, Barbara Cantoni5

  • 1Department of Emergency Medicine and Trauma Center, niccolo.parri@meyer.it.

Pediatrics
|September 24, 2020
PubMed

Insights

Pediatric COVID-19 cases often present with mild symptoms, posing challenges for emergency departments. Early recognition is key for disease control, as children can transmit the virus.

Area of Science:

  • Pediatric Infectious Diseases
  • Emergency Medicine
  • Public Health

Background:

  • Coronavirus disease 2019 (COVID-19) presents variably in children, complicating early recognition in emergency departments (EDs).
  • Effective disease control and prevention strategies depend on accurate identification of pediatric COVID-19 cases.

Purpose of the Study:

  • To describe a cohort of 170 children diagnosed with COVID-19 in Italian pediatric EDs.
  • To compare findings with previously published pediatric COVID-19 cohorts.

Main Methods:

  • Retrospective chart review of children aged 0-18 years.
  • Data collected from 17 pediatric emergency departments across Italy.

Main Results:

  • A high proportion of patients were under one year old (median age 45 months).
  • Most children presented with asymptomatic (17%) or mild (63%) disease, with cough and feeding difficulties being common symptoms.
  • Radiological imaging was minimally utilized, potentially leading to under-identification of moderate cases.

Conclusions:

  • Pediatric COVID-19 cases in Italian EDs often lack severe symptoms, representing an organizational challenge rather than a frequent severe illness.
  • Children can be significant sources of viral transmission, necessitating continued vigilance and preparedness.
  • A clinical classification approach may be more effective than radiological methods for resource allocation and predicting patient needs.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
165
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
147
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
335
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
848
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
617